Kyverna reports positive 1 — year KYSA — 8 trial data for miv — cel in stiff person syndrome
Kyverna reported positive one-year durability data for miv-cel in stiff person syndrome from its KYSA-8 registrational trial. Key trial endpoints were previously presented at AAN 2026; the full one-year dataset will be presented at MS Toronto on Oct. 21-23, 2026. Results showed sustained clinical benefit through one ye